arrow
M

Marisol Huerta

incliva biomedical research institute
H指数:22
被引数:2,009

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Spatial Dynamics Links PD-L1 and Tumor-Associated Macrophage-Enriched Niches to Immune and Mesenchymal States in Microsatellite-Stable Colorectal Cancer

空间动力学将PD-L1与肿瘤相关巨噬细胞富集的微环境与免疫和间质状态联系起来,在微卫星稳定型结直肠癌中

Cancers
IF4.4
2026-04-180
OAAI
A radiomics-based artificial intelligence model to assess the risk of relapse in localized colon cancer

一种基于放射组学的人工智能模型,用于评估局部结肠癌的复发风险

2025-07-160
OAAI
Extended tumor area-based stratification score combining tumor budding and stroma identifies a high-risk, immune-depleted group in localized microsatellite-stable colon cancer patients

基于扩展肿瘤区域并结合肿瘤出芽和间质的分层评分可识别局部微卫星稳定型结直肠癌患者中的高风险、免疫耗竭组

2025-05-010
PRE
Decoding chromosomal instability insights in CRC by integrating omics and patient-derived organoids

通过整合组学和患者源性类器官解码结直肠癌中的染色体不稳定性见解

2025-02-280
OA
ctDNA whole exome sequencing in pancreatic ductal adenocarcinoma unveils organ-dependent metastatic mechanisms and identifies actionable alterations in fast progressing patients
2024-09-011
PRE
COMPReS study: Multiomic profiling reveals organ-specific differences in metastases and identifies novel predictive biomarkers in relapsed localized colon cancer

COMPReS研究:多组学分析揭示了转移灶的器官特异性差异,并识别出局部复发结肠癌的新型预测性生物标志物

2024-09-011
PRE
Sequencing paired tumor DNA and white blood cells improves circulating tumor DNA tracking and detects pathogenic germline variants in localized colon cancer
2023-12-014
OAAI
Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction

用于药物敏感性预测的晚期结直肠癌患者衍生的类器官的蛋白质转录组学分析

2023-01-0629
OAAI
Integrative immune transcriptomic classification improves patient selection for precision immunotherapy in advanced gastro-oesophageal adenocarcinoma
2022-10-173
OA
Epigenetic engineering on CDX2 allows to determine the interplaying consequences with other genetic and transcriptomic events in colorectal cancer
2022-09-010
OAAI
Molecular profiling of advanced solid tumours. The impact of experimental molecular-matched therapies on cancer patient outcomes in early-phase trials: the MAST study
2021-09-0719
OAAI
Exome sequencing of ctDNA portrays the mutational landscape of patients with relapsing colon cancer and indicates new actionable targets
2021-09-011
OAAI
Characterizing diversity in the immune profile by a transcriptomic customized gene signature to potentially personalize treatment in advanced gastric cancer patients
2021-09-010
OAAI
Metastatic colorectal cancer derived organoids recapitulate genomic profile and treatment response of the original tumor
2020-09-010
OAAI